Replies to post #685876 on ORIONS Money Stocks

[AugustaFriends]

$IMRX $2.14:cancer news conference tomorrow on Phase 2 update.

One to keep an eye for sure 👀 😏

https://finance.yahoo.com/news/immuneering-updates-phase-2a-clinical-120000323.html

[AugustaFriends]

$IMRX waiting for todays GAP to close $BON looking good 👍 👌

[AugustaFriends]

$IMRX got a few at 2.11

[georgie18]

IMRX...$2.35...🥳

georgie18

Member Level
Re: georgie18 post# 389758

Monday, June 16, 2025 8:31:26 AM

Post#
394384
of 394426
IMRX...$2.15...🥳... CAMBRIDGE, Mass., June 16, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company outpacing cancer to help patients outlive their disease, today announced that it will host a conference call and live webcast at 8:00 am ET on June 17, 2025. The company is excited to provide updates from its ongoing Phase 2a clinical trial of IMM-1-104 in first-line pancreatic cancer patients.

The conference call will be webcast live and archived in the Investor Relations section of Immuneering’s website at Events & Presentations | Immuneering Corporation.